P3 Health Partners Inc.
PIII
$6.68
$0.335.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -104.58% | -135.14% | 18.71% | 44.07% | 74.97% |
| Total Depreciation and Amortization | -1.27% | -0.71% | -0.58% | -0.63% | -0.46% |
| Total Amortization of Deferred Charges | -81.57% | -81.57% | -80.25% | -- | -- |
| Total Other Non-Cash Items | -19.18% | -9.36% | -112.51% | -49.78% | -787.67% |
| Change in Net Operating Assets | 128.86% | 190.38% | 472.26% | 183.75% | -15.30% |
| Cash from Operations | -70.82% | -44.85% | 25.34% | 49.06% | 40.69% |
| Capital Expenditure | -- | -- | 110.66% | 92.95% | 25.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 1,165.66% | 895.02% | 864.81% | 97.81% | 80.66% |
| Total Debt Issued | 819.92% | 537.74% | -7.66% | -7.67% | -59.21% |
| Total Debt Repaid | -7,082.33% | -- | -- | 11.79% | 82.22% |
| Issuance of Common Stock | -51.63% | -51.57% | -51.60% | -51.60% | -- |
| Repurchase of Common Stock | -117.74% | -148.67% | -2,816.47% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -115.23% | -75.29% | -352.02% | -264.16% | -- |
| Cash from Financing | 20.89% | -1.56% | -44.73% | -42.11% | 265.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -62.44% | -85.91% | -51.73% | 693.94% | 123.39% |